Virtual Medicinal Product (VMP)
-
Ponatinib 45mg tablets
Name Details
Current Name
Ponatinib 45mg tablets
|
Start Date
15-11-2013
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01EA05
BNF |
Current BNF
08010500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010500
|
Start Date
16-06-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41768211000001105 |
09-05-2023 |
|
703800009 |
01-10-2014 |
08-05-2023 |
23604811000001103 |
15-11-2013 |
30-09-2014 |
VMP Ingredients
Name
Ponatinib hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Ponatinib
Strength and UOM (Nmr)
45.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Ponatinib
-
VMP
(Current) Ponatinib 45mg tablets
Virtual Medicinal Product Pack (VMPP) Information